Join

Compare · QNRX vs RMD

QNRX vs RMD

Side-by-side comparison of Quoin Pharmaceuticals Ltd. (QNRX) and ResMed Inc. (RMD): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both QNRX and RMD operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
  • RMD is the larger of the two at $28.57B, about 2873.5x QNRX ($9.9M).
  • Over the past year, QNRX is down 45.4% and RMD is down 22.0% - RMD leads by 23.4 points.
  • RMD has been more active in the news (7 items in the past 4 weeks vs 5 for QNRX).
  • RMD has more recent analyst coverage (25 ratings vs 0 for QNRX).
PerformanceQNRX-45.40%RMD-21.97%
2025-06-10+0.00%2026-06-09
MetricQNRXRMD
Company
Quoin Pharmaceuticals Ltd.
ResMed Inc.
Price
$4.81+3.89%
$196.95+1.94%
Market cap
$9.9M
$28.57B
1M return
-23.77%
-4.76%
1Y return
-45.40%
-21.97%
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Exchange
NASDAQ
NYSE
IPO
2016
News (4w)
5
7
Recent ratings
0
25
QNRX

Quoin Pharmaceuticals Ltd.

Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.

RMD

ResMed Inc.

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep apnea, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, portable oxygen concentrators, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides U-Sleep, which enables automated patient coaching through a text, email, or interactive voice phone call; AirView that enables remote monitoring, over-the-air trouble shooting, and changing of device settings; and myAir, a patient engagement application that offers sleep data and a daily score based on their previous night's data, as well as connectivity module and propeller solutions. In addition, it provides business management software and services to out-of-hospital providers, home medical equipment, pharmacy, home infusion, orthotics, and prosthetics; and HEALTHCAREfirst and MatrixCare solutions. The company markets its products to sleep clinics, home healthcare dealers, patients, hospitals, physicians, and third-party payers through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Latest QNRX

Latest RMD